Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-08

Clinical Trial Update: Effects of Adding Hypertonic Saline Solutions and/or Etilefrine to Standard Diuretics Therapy in Hepatic Ascites [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adding hypertonic saline solutions and/or etilefrine to standard diuretic therapy for hepatic ascites has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etilefrine (Etilefrine)
  • Hypertonic saline solutions

Snippet

Sponsor: Hala Abd EL-Tawab Ibrahim Radwan | Conditions: Hepatic Ascites | Phase 2 | Status: COMPLETED